MyAverix Finance
MC · Healthcare
Laboratorios Farmaceuticos ROVI (ROVI)
Drug Manufacturers - Specialty & Generic
Laboratorios Farmaceuticos ROVI (ROVI) is listed on MC in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported market cap is $3.02B, P/E ratio is 25.02, net margin is 18.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ROVI
Laboratorios Farmaceuticos ROVI (ROVI) — FAQ
What is Laboratorios Farmaceuticos ROVI's market cap?
Laboratorios Farmaceuticos ROVI (ROVI) has a reported market cap of $3.02B (data as of 2026-05-24).
What is ROVI's P/E ratio?
The price-to-earnings (P/E) ratio for Laboratorios Farmaceuticos ROVI (ROVI) is 25.02 (data as of 2026-05-24).
Does Laboratorios Farmaceuticos ROVI pay a dividend?
Dividend yield is not available in the current snapshot for Laboratorios Farmaceuticos ROVI (ROVI). Check the MyAverix Finance app for the latest dividend data.
What sector is Laboratorios Farmaceuticos ROVI in?
Laboratorios Farmaceuticos ROVI (ROVI) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is ROVI listed on?
ROVI is listed on MC.
What is Laboratorios Farmaceuticos ROVI's net margin?
Laboratorios Farmaceuticos ROVI (ROVI) reports a net margin of 18.9% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.